NCT06267976View on ClinicalTrials.gov

Validation of the ProSomnus® RPMO2 Device

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

September 15, 2024

Study Completion Date

June 30, 2025

Conditions
Healthy
Interventions
DEVICE

ProSomnus RPMO2

The ProSomnus RPMO2 device is an intraoral reflectance pulse oximeter.

Trial Locations (1)

T2N4N1

University of Calgary, Calgary

Sponsors
All Listed Sponsors
lead

ProSomnus Sleep Technologies

INDUSTRY

NCT06267976 - Validation of the ProSomnus® RPMO2 Device | Biotech Hunter | Biotech Hunter